Cargando…

Indoleamine 2,3‐dioxygenase 1 in coronary atherosclerotic plaque enhances tissue factor expression in activated macrophages

BACKGROUND: Recent clinical studies have found that changes in the kynurenine (Kyn) pathway of tryptophan (Trp) metabolism are associated with cardiovascular events. However, the roles of the Kyn pathway on vascular wall thrombogenicity remain unknown. Indoleamine 2,3‐dioxygenase 1 (IDO1) is a rate‐...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Yuki, Koyama, Shohei, Yamashita, Atsushi, Matsuura, Yunosuke, Nishihira, Kensaku, Kitamura, Kazuo, Asada, Yujiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles: Thrombosis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178752/ https://www.ncbi.nlm.nih.gov/pubmed/30349892 http://dx.doi.org/10.1002/rth2.12128

Ejemplares similares

Chlamydia pneumoniae is Prevalent in Symptomatic Coronary Atherosclerotic Plaque Samples Obtained From Directional Coronary Atherectomy, but its Quantity is Not Associated With Plaque Instability: An Immunohistochemical and Molecular Study
por: Otani, Tomoyuki, et al.
Publicado: (2022)

The Btk inhibitor AB‐95‐LH34 potently inhibits atherosclerotic plaque–induced thrombus formation and platelet procoagulant activity
por: Smith, Christopher W., et al.
Publicado: (2022)

Localization of Indoleamine 2,3-Dioxygenase-1 and Indoleamine 2,3-Dioxygenase-2 at the Human Maternal-Fetal Interface
por: Kudo, Yoshiki, et al.
Publicado: (2020)

Visualization of a Rapidly Progressing Lipid-Rich Plaque Causing No-Reflow Phenomenon During Percutaneous Coronary Intervention　― Insights From Near-Infrared Spectroscopy and Histopathology ―
por: Honda, Yasuhiro, et al.
Publicado: (2019)

Pathophysiology of atherothrombosis: Mechanisms of thrombus formation on disrupted atherosclerotic plaques
por: Asada, Yujiro, et al.
Publicado: (2020)

Th17/Treg balance and indoleamine 2,3 dioxygenase activity in periodontitis-associated atherosclerotic patients
por: Yang, Jie, et al.
Publicado: (2022)

Upregulated Kynurenine Pathway Enzymes in Aortic Atherosclerotic Aneurysm: Macrophage Kynureninase Downregulates Inflammation
por: Nishimura, Masanori, et al.
Publicado: (2021)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
por: Brochez, Lieve, et al.
Publicado: (2021)

Targeting the indoleamine 2,3-dioxygenase pathway in cancer
por: Moon, Yong Wha, et al.
Publicado: (2015)

The Mechanism of Substrate Inhibition in Human Indoleamine 2,3-Dioxygenase
por: Efimov, Igor, et al.
Publicado: (2012)

Indoleamine-2,3-dioxygenase activity induces neutrophil apoptosis
por: Van der Sluijs, K, et al.
Publicado: (2011)

Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
por: Padberg, Jan-Sören, et al.
Publicado: (2012)

The role of placental indoleamine 2,3-dioxygenase in human pregnancy
por: Kudo, Yoshiki
Publicado: (2013)

Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry
por: Coletti, Alice, et al.
Publicado: (2017)

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
por: Mellor, Andrew L., et al.
Publicado: (2017)

Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract
por: Acovic, Aleksandar, et al.
Publicado: (2018)

Role of indoleamine 2,3-dioxygenase in testicular immune-privilege
por: Gualdoni, Gisela S., et al.
Publicado: (2019)

A narrative review of the roles of indoleamine 2,3-dioxygenase and tryptophan-2,3-dioxygenase in liver diseases
por: Zhou, Qihui, et al.
Publicado: (2021)

Pathological Features of Ruptured Coronary Plaque and Thrombus Interfaces: Fibrin and von Willebrand Factor as Platelet Scaffolds on Rupture Sites
por: Yamashita, Atsushi, et al.
Publicado: (2021)

Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase
por: Yoshioka, Saeko, et al.
Publicado: (2022)

Indoleamine 2,3-Dioxygenase in Human Hematopoietic Stem Cell Transplantation
por: Jürgens, Birgit, et al.
Publicado: (2010)

The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
por: Gao, Yan-Fang, et al.
Publicado: (2009)

The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis
por: Shibata, Yuhei, et al.
Publicado: (2016)

Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors
por: Zulfiqar, Bilal, et al.
Publicado: (2017)

The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
por: Hornyák, Lilla, et al.
Publicado: (2018)

Hypoxia enhances indoleamine 2,3-dioxygenase production in dendritic cells
por: Song, Xiang, et al.
Publicado: (2018)

Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer
por: Zhang, Tao, et al.
Publicado: (2017)

Comprehensive behavioral analysis of indoleamine 2,3‐dioxygenase knockout mice
por: Hirata, Nao, et al.
Publicado: (2018)

Indoleamine-2,3-Dioxygenase 1 Deficiency Suppresses Seizures in Epilepsy
por: Deng, Ning, et al.
Publicado: (2021)

Local Inhibition of Indoleamine 2,3-Dioxygenase Mitigates Renal Fibrosis
por: Jensen, Camilla Grønkjær, et al.
Publicado: (2021)

Indoleamine-2,3-Dioxygenase as a Perioperative Marker of the Immune System
por: Bello, Corina, et al.
Publicado: (2021)

Indoleamine 2,3-Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma
por: Farooq, Asim, et al.
Publicado: (2023)

Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment
por: Azimnasab-sorkhabi, Parviz, et al.
Publicado: (2023)

Expression Pattern and Clinicopathological Relevance of the Indoleamine 2,3-Dioxygenase 1/Tryptophan 2,3-Dioxygenase Protein in Colorectal Cancer
por: Chen, I-Chien, et al.
Publicado: (2016)

A Rabbit Model of Thrombosis on Atherosclerotic Lesions
por: Yamashita, Atsushi, et al.
Publicado: (2011)

Involvement of enhanced expression of classical complement C1q in atherosclerosis progression and plaque instability: C1q as an indicator of clinical outcome
por: Sasaki, Shoh, et al.
Publicado: (2022)

Variable indoleamine 2,3‐dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapy
por: Iga, Natsuko, et al.
Publicado: (2019)

Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer
por: Ino, K, et al.
Publicado: (2006)

Natural CD4(+) T-Cell Responses against Indoleamine 2,3-Dioxygenase
por: Munir, Shamaila, et al.
Publicado: (2012)

Alzheimer’s and Seizures: Interleukin-18, Indoleamine 2,3-Dioxygenase and Quinolinic Acid
por: Anderson, G, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2ajs0i1b00g1f0scbi4hdlqjck